Bupropion SR for the treatment of nicotine dependence in patients with chronic bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002
Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004
Influence of statin therapy on exacerbation frequency in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
The treatment of tobacco dependence: an effective treatment for COPD Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases Year: 2012
Evaluating the efficacy of chronic therapy with tiotropium in COPD through discontinuation of treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002
Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
Efficacy of bupropion therapy in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 153s Year: 2004
Characteristics of patients treated with nicotine replacement therapy (NRT) prescribed during hospitalization Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations Year: 2019
Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 156s Year: 2004
Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018
The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006
Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008
Pharmacological treatment for smoking cessation Source: Eur Respir Mon; 2008: 42: 74–97 Year: 2008
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004
Combination therapy of inhaled corticosteroids and long-acting beta2 -agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006
Comparison of nicotine patch and bupropion in treating tobacco dependence Source: Eur Respir J 2005; 26: Suppl. 49, 388s Year: 2005